Global X Genomics & Biotechnology ETF
GNOM
45 hedge funds and large institutions have $88.3M invested in Global X Genomics & Biotechnology ETF in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
113% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 8
18% more funds holding
Funds holding: 38 → 45 (+7)
16% more capital invested
Capital invested by funds: $76.4M → $88.3M (+$11.8M)
0.41% less ownership
Funds ownership: 9.23% → 8.82% (-0.41%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$3.29M |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$3.16M |
| 3 |
T
TRUADVICE
Sarasota,
Florida
|
+$683K |
| 4 |
OC
Oppenheimer & Co
New York
|
+$522K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
+$469K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$2.65M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.63M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.29M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$525K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$518K |
GNOM Hedge Fund Activity: Q2 2021 in Review
45 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q2 2021, worth a combined $88.3M — up 16% from $76.4M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new GNOM positions and 5 closed out — a net gain of 7 holders — while 17 added to existing stakes and 8 trimmed.
The largest buyer was Private Advisor Group, opening a new position worth an estimated $3.29M. The largest seller was Mirae Asset Global Investments, cutting an estimated $2.65M.
- 45 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q2 2021, up from 38 in Q1 2021.
- Funds reported $88.3M of Global X Genomics & Biotechnology ETF stock for Q2 2021, up 16% quarter-over-quarter.
- 12 funds opened new Global X Genomics & Biotechnology ETF positions in Q2 2021 and 5 closed out, a net change of +7 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q2 2021 was Private Advisor Group, an estimated $3.29M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q2 2021 was Mirae Asset Global Investments, an estimated $2.65M sold.
Based on aggregated 13F filings for Q2 2021.